Valuation: Bio-Rad Laboratories, Inc.

Market Cap 784.8Cr 688.34Cr 635.5Cr 587.26Cr 1.11TCr 75TCr 1.14TCr 7.64TCr 2.97TCr 37TCr 2.95TCr 2.88TCr 1,27700Cr P/E 2026 *
35.2x
P/E 2027 * 34.4x
Enterprise Value 709.89Cr 622.65Cr 574.84Cr 531.21Cr 1.01TCr 68TCr 1.03TCr 6.91TCr 2.69TCr 33TCr 2.67TCr 2.61TCr 1,15500Cr EV / Sales 2026 *
2.77x
EV / Sales 2027 * 2.61x
Free-Float
60.28%
Yield 2026 *
-
Yield 2027 * -
1 day-3.36%
1 week-4.92%
Current month-3.51%
1 month-2.29%
3 months+2.57%
6 months-9.00%
Current year-3.21%
1 week 247
Extreme 247
262.4
1 month 235.8
Extreme 235.8
263.2
Current year 204.6
Extreme 204.6
278.4
1 year 204.6
Extreme 204.6
294.7
3 years 187.35
Extreme 187.35
383.8
5 years 187.35
Extreme 187.35
700
10 years 128.72
Extreme 128.72
700
Manager TitleAgeSince
Chief Executive Officer 76 01/01/2003
President 61 09/09/2024
Director of Finance/CFO 55 15/04/2024
Director TitleAgeSince
Chairman 76 01/01/2012
Director/Board Member 73 25/04/2017
Director/Board Member 79 25/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-3.36%-4.92% - - 784.8Cr
-0.38%+3.50%-28.46%-10.85% 17TCr
-2.05%+3.75%-7.24%-4.95% 11TCr
+1.25%+7.04%+3.59%+60.10% 5.92TCr
-6.77%-7.86%+44.51%+46.55% 5.3TCr
-3.06%-0.93%-13.25%-41.18% 4.31TCr
-5.29%-1.99% - - 3.64TCr
+0.22%+7.07%-11.97%-43.55% 2.84TCr
-0.87%-3.28%+60.12%-6.43% 2.52TCr
-2.04%+1.90%-7.08%+5.37% 2.12TCr
Average -2.23%+4.89%+5.03%+0.63% 6.01TCr
Weighted average by Cap. -1.77%+5.25%-4.97%+1.24%

Financials

2026 *2027 *
Net sales 256.72Cr 225.17Cr 207.88Cr 192.1Cr 364.1Cr 25TCr 371.39Cr 2.5TCr 971.01Cr 12TCr 964.05Cr 942.92Cr 42TCr 263.48Cr 231.1Cr 213.36Cr 197.16Cr 373.7Cr 25TCr 381.18Cr 2.56TCr 996.59Cr 12TCr 989.44Cr 967.76Cr 43TCr
Net income 22Cr 20Cr 18Cr 17Cr 32Cr 2.15TCr 33Cr 218.88Cr 85Cr 1.05TCr 84Cr 83Cr 3.66TCr 23Cr 20Cr 19Cr 17Cr 33Cr 2.2TCr 33Cr 223.62Cr 87Cr 1.08TCr 86Cr 84Cr 3.74TCr
Net Debt -75Cr -66Cr -61Cr -56Cr -106.23Cr -7.17TCr -108.36Cr -729.14Cr -283.31Cr -3.51TCr -281.28Cr -275.11Cr -12TCr -97Cr -85Cr -78Cr -72Cr -136.93Cr -9.24TCr -139.67Cr -939.8Cr -365.16Cr -4.52TCr -362.54Cr -354.6Cr -16TCr
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change
08/26/08 247.60 -3.28%
07/26/07 €256.00 -0.54%
06/26/06 €257.40 -0.08%
03/26/03 €257.60 -0.39%
02/26/02 €258.60 -0.69%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
292.50USD
Average target price
297.00USD
Spread / Average Target
+1.54%

Quarterly revenue - Rate of surprise